Global psychedelics company Silo Wellness announced on Wednesday that it is partnering with Los Angeles-based Kaivalya Kollectiv to offer psychedelic retreats utilizing the chemical 5-MeO-DMT. The partnership expands Silo’s portfolio of psychedelic product and retreat offerings, which currently include psilocybin and ketamine.
Douglas K. Gordon, CEO of Silo Wellness, noted in a press release from the company that emerging psychedelic therapies can provide new opportunities for mental health and wellness.
“Psychedelic experiences can be profoundly transformative and deeply healing,” said Gordon. “We are pleased to expand our portfolio to include 5-MeO-DMT retreats, especially at a time when so many people are struggling with mental health issues and looking for plant-based alternatives to help guide them on their paths to greater self-actualization.”
Under the newly announced partnership, Silo Wellness will operate two 5-MeO-DMT retreats in Jamaica, where the company already conducts psilocybin-assisted retreats and mushroom and truffle cultivation workshops.
Kaivalya Kollectiv is a California wellness company that conducts psychedelic-integrated spiritual coaching and facilitated retreats in Mexico, Jamaica, and Costa Rica. Joël Brierre, founder and CEO of the company, said that “everyone on the planet should have access to the life-changing properties of psychedelics.”
“When used properly, 5-MeO-DMT can be one of the most powerful tools known